KARVEZIDE Side Effects

6281957-3 | Hyponatraemia
on Jul 20, 2009 Female patient from AUSTRALIA , 72 years of age, was diagnosed with essential hypertension, metabolic disorder (What is metabolic disorder?) and was treated with Karvezide (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Karvezide dosage: 1 Df=300/12.5 Mg. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), SOMAC (View Somac Review and Somac Label ), ZANIDIP (View Zanidip Review and Zanidip Label ). Patient was hospitalized.

6052730-6 | Fall, Somnolence
Patient was taking Karvezide (View Usage). Patient had the following side effects: fall (What is fall?), somnolence on Jan 21, 2009 from AUSTRALIA Additional patient health information: Female patient , 77 years of age, . Karvezide dosage: 1 Dosage Form = 300 / 12.5 Mg Morning.. During the same period patient was treated with EPILIM (1 Dosage Form = 200mg Morning, 400mg Night) (View Epilim Review and Epilim Label ), SIMVAR (1 Dosage Form = 80 Mg , Bedtime.) (View Simvar Review and Simvar Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MULTI B FORTE (At Morning.) (View Multi-b Forte Review and Multi-b Forte Label ), CARTIA XT (At Morning.) (View Cartia Xt Review and Cartia Xt Label ), EFFEXOR XR (At Morning.) (View Effexor Xr Review and Effexor Xr Label ). Patient was hospitalized.

6019249-X | Ageusia, Olfactory Nerve Disorder
Adverse event was reported on Dec 22, 2008 by a Female patient taking Karvezide (View Usage) (Dosage: Also Taken 150 Mg From 2001 To Aug-2004, 300 Mg Oral Sep-2004 To 11-aug-2008) was diagnosed with hypertension and. Location: GERMANY , 68 years of age, weighting 152.1 lb, After Karvezide was administered, patient had the following side effects: ageusia, olfactory nerve disorder.

5962807-9 | Ageusia, Olfactory Nerve Disorder
on Nov 20, 2008 Female patient from GERMANY , 68 years of age, weighting 152.1 lb, was diagnosed with hypertension and was treated with Karvezide (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, olfactory nerve disorder. Karvezide dosage: Also Taken 150 Mg From 2001 To Aug-2004, 300 Mg Oral Sep-2004 To 11-aug-2008.


5943798-3 | Normochromic Normocytic Anaemia
on Oct 24, 2008 Male patient from AUSTRALIA , 82 years of age, was treated with Karvezide (View Usage). Patient had the following side effects: normochromic normocytic anaemia. Karvezide dosage: .

5935863-1 | Psoriasis, Skin Exfoliation
Patient was taking Karvezide (View Usage). After Karvezide was administered, patient had the following side effects: psoriasis, skin exfoliation on Oct 28, 2008 from SPAIN Additional patient health information: Male patient , 81 years of age, . Karvezide dosage: 1 Dosage Form = 300/12.5 Mg. During the same period patient was treated with CALCIUM ANTAGONIST (View Calcium Antagonist Review and Calcium Antagonist Label ).

5248017-1 | Diarrhoea, Proctalgia
Adverse event was reported on Feb 23, 2007 by a Female patient taking Karvezide (View Usage) (Dosage: ) . Location: AUSTRALIA , 70 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, proctalgia. During the same period patient was treated with TRITACE (View Tritace Review and Tritace Label ).

4939337-6 | Gastroenteritis, Guillain-barre Syndrome
on Oct 21, 2005 Male patient from SPAIN , 38 years of age, was treated with Karvezide (View Usage). Patient had the following side effects: gastroenteritis (What is gastroenteritis?), guillain-barre syndrome (What is guillain-barre syndrome?). Karvezide dosage: ^300 Mg^. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

4920646-1 | Gastroenteritis, Guillain-barre Syndrome
on Oct 21, 2005 Male patient from SPAIN , 38 years of age, was treated with Karvezide (View Usage). After Karvezide was administered, patient had the following side effects: gastroenteritis (What is gastroenteritis?), guillain-barre syndrome (What is guillain-barre syndrome?). Karvezide dosage: ^300 Mg^. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

4887381-X | Gastrointestinal Infection, Guillain-barre Syndrome, Intervertebral Disc Protrusion
Patient was taking Karvezide (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal infection, guillain-barre syndrome (What is guillain-barre syndrome?), intervertebral disc protrusion on Oct 21, 2005 from SPAIN Additional patient health information: Male patient , 38 years of age, . Karvezide dosage: . During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.